KIMBERLY WALLS: Open Payments
NPI 1760996128 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 21 payments from 11 companies in 2025. Trend: 2023 $127 · 2024 $52 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $140 |
| Corcept Therapeutics | 4 | $110 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Dexcom, Inc. | 2 | $50 |
| Abbott Laboratories | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ABIOMED | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: AIRSUPRA, Korlym, FANAPT, TRELEGY ELLIPTA, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, REXULTI, Auvelity.
Industry payments across AZ — which companies pay providers there.
